Literature DB >> 961582

Effect of beta-adrenergic blockade with alprenolol on ST-segment depression and circulatory dynamics during exercise in patients with effort angina.

I K Bailey, S D Anderson, P J Rozea, L Bernstein, G Nyberg, P I Korner.   

Abstract

1. Nine subjects with severe coronary artery disease were studied during graded "sprint" and "steady-state" exercise before and after intravenous administration of the beta-receptor antagonist alprenolol. During "sprint" workload was increased every minute until maximum work capacity (Wmax) was reached. "Steady-state" exercise was performed at work rates of 0.250, 0.50, and 0.75 of each subject's sprint Wmax. Variables measured included ST-segment depression, changes in heart rate, blood pressure, respiratory gas exchange, and arterial blood composition. Cardiac output (indirect Fick) was measured during "steady-state" exercise. 2. Alprenolol did not alter Wmax during "sprint" but reduced the incidence of angina in both types of exercise. After the drug work capacity was limited by symptoms and signs suggestive of mild left ventricular failure. 3. The relationship between workload (normalized in terms of Wmax) and ST-segment depression was curvilinear. Under control conditions a given rate of work during "steady-state" exercise was assocaited with more marked ST-segment depression than during "sprint". Alprenolol displaced the work-ST-depression curve to the right in each type of exercise; now a given rate of work produced similar ST-depressing during "steady-state" and "sprint" exercise. 4. Alprenolol attentuated the exercise tachycardia during both types of exercise. Cardiac output was lower in "steady-state" exercise after the drug than under control conditions. Metabolic effects included significant reduction in body oxygen consumption after alpreprenolol at 0.25 Wmax and diminished arterial lactate at 0.75 Wmax. The beneficial effects of the drug thus appeared to involve not only cardiac but peripheral effects on beta receptors. 5. Before alprenolol cardiac output was relatively fixed at all workloads, but after the drug there was a work-related rise in output in five out of nine subjects. Comparison with data in normal subjects suggested that in anginal subjects cardiac output at low "steady-state" workloads was inappropriately high.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 961582     DOI: 10.1016/s0002-8703(76)80040-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Influence of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on the heart rate and blood pressure responses to graded exercise.

Authors:  G Jennings; A Bobik; P Korner
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

2.  Effects of labetalol and propranolol on blood pressure at rest and during isometric and dynamic exercise.

Authors:  G Nyberg; A Vedin; C Wilhelmsson
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

3.  Effects of beta blockade on work--delta ST segment curves during exercise, and relation to subsequent results of coronary artery bypass surgery.

Authors:  G Jennings; A Pitt; G Stirling; P Korner
Journal:  Br Heart J       Date:  1980-04

4.  Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.

Authors:  P J Currie; M J Kelly; K Middlebrook; J Federman; E Sainsbury; J Ashley; A Pitt
Journal:  Br Heart J       Date:  1984-05

5.  Stereoselective steady state disposition and action of propafenone in Chinese subjects.

Authors:  G Li; P L Gong; J Qiu; F D Zeng; U Klotz
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

6.  Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia.

Authors:  G L Jennings; A Bobik; E T Fagan; P I Korner
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.